Edit Code of Life, Creating Transformative Solutions for Serious Human Diseases

> About Us> Leadership

Ming JinPh.D.

R&D Director, High-throughput Screening Platform

Dr. Ming Jin has nearly 10 years of experience in healthcare industry. 

She is skilled in high-throughput genome editing screening and early stage drug target screening and validation. 


Dr. Ming Jin holds BS in Biology and MS in molecular biology from Lanzhou University, Ph.D. in chemistry and pharmacy from LMU Munich and completed her post-doctoral research at Helmholtz Institute.